Summary of Purpose
Ischemic stroke is a leading cause of death and disability worldwide. Atherosclerosis, responsible for the 20% of ischemic strokes, is characterized by lipid accumulation in the artery wall that leads to chronic inflammation, cell proliferation and ultimately to vessel stenosis. One of the main features related to plaque progression and vulnerability is inflammation. Positron emission tomography with...Read More →
The following dates are available for this trial. Trial information last updated on 12 July 2017.
|1 Oct 2015||5 Jul 2017||31 Dec 2018||31 Dec 2018||1 Jul 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Pol Camps-Remom, MD